Higher Cost Sharing Reduces Treatment Adherence, Drug Usage
Study finds higher cost sharing reduces treatment adherence and drug usage.
- "Insuring All Children -- The New Political Imperative," New England Journal of Medicine: In the health policy report, NEJMnational correspondent John Iglehart discusses the history of SCHIP andthe program's effect on access and quality. Iglehart also discusses thedebate in Congress over reauthorizing and expanding SCHIP, whichexpires on Sept. 30, as well as the Bush administration's proposal torestrict program eligibility to children in families with annualincomes less than 200% of the federal poverty level.
- "Prescription Drug Cost Sharing: Associations With Medication and Medical Utilization and Spending and Health," Journal of the American Medical Association:The study analyzes studies published between 1985 and 2006 to determinethe effects of prescription drug cost sharing on the use of medicationsand nondrug treatments and on health outcomes. Researchers found thatmore cost sharing led to reduced drug usage and adherence to treatmentregimens, as well as more frequent discontinuation of therapy. Thestudy found that for every 10% increase in cost sharing, drug spendingfell by 2% to 6% (Goldman et al., JAMA, 7/4).
Reprinted with permission from kaisernetwork.org. Youcan view the entire Kaiser DailyHealth Policy Report, search the archives, and sign up for email deliveryat kaisernetwork.org/email. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, afree service of The Henry J. Kaiser Family Foundation.